Dr Reddy#39;s enters licensing pact with CHD Bioscience to develop and commercialise latter#39;s antibiotic gel

Under the terms of the agreement, DRL would receive equity in CHD valued at USD 30 million upon an IPO of CHD or a minimum of USD 30 million in cash w...